These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9388873)
1. [Massive apoptosis in P815 mastocytoma in vivo induced by interleukin 2 gene transduction]. Guo N; Li X; Liu X Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):284-7. PubMed ID: 9388873 [TBL] [Abstract][Full Text] [Related]
2. IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL. Levraud JP; Duffour MT; Cordier L; Perricaudet M; Haddada H; Kourilsky P J Immunol; 1997 Apr; 158(7):3335-43. PubMed ID: 9120291 [TBL] [Abstract][Full Text] [Related]
3. Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences. Kamate C; Baloul S; Grootenboer S; Pessis E; Chevrot A; Tulliez M; Marchiol C; Viguier M; Fradelizi D Int J Cancer; 2002 Aug; 100(5):571-9. PubMed ID: 12124807 [TBL] [Abstract][Full Text] [Related]
4. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. Fioretti F; Fradelizi D; Stoppacciaro A; Ramponi S; Ruco L; Minty A; Sozzani S; Garlanda C; Vecchi A; Mantovani A J Immunol; 1998 Jul; 161(1):342-6. PubMed ID: 9647242 [TBL] [Abstract][Full Text] [Related]
5. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185 [TBL] [Abstract][Full Text] [Related]
6. Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Haddada H; Ragot T; Cordier L; Duffour MT; Perricaudet M Hum Gene Ther; 1993 Dec; 4(6):703-11. PubMed ID: 8186285 [TBL] [Abstract][Full Text] [Related]
7. LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. Abina MA; Lee MG; Descamps V; Cordier L; Lopez M; Perricaudet M; Haddada H Gene Ther; 1996 Mar; 3(3):212-6. PubMed ID: 8646551 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. Grohmann U; Silla S; Belladonna ML; Bianchi R; Orabona C; Puccetti P; Fioretti MC Cell Immunol; 1997 Nov; 181(2):109-19. PubMed ID: 9398398 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo. Ley V; Langlade-Demoyen P; Kourilsky P; Larsson-Sciard EL Eur J Immunol; 1991 Mar; 21(3):851-4. PubMed ID: 2009918 [TBL] [Abstract][Full Text] [Related]
10. Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression. Cignetti A; Guarini A; Carbone A; Forni M; Cronin K; Forni G; Gansbacher B; Foa R J Natl Cancer Inst; 1994 May; 86(10):785-91. PubMed ID: 8169977 [TBL] [Abstract][Full Text] [Related]
11. Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. Cordier L; Duffour MT; Sabourin JC; Lee MG; Cabannes J; Ragot T; Perricaudet M; Haddada H Gene Ther; 1995 Jan; 2(1):16-21. PubMed ID: 7712329 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
13. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism. La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB J Immunol; 1999 Apr; 162(8):4817-23. PubMed ID: 10202025 [TBL] [Abstract][Full Text] [Related]
14. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors. Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous immune rejection of intraocular tumors in mice. Niederkorn JY; Meunier PC Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853 [TBL] [Abstract][Full Text] [Related]
17. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells]. Medvedev AE; Fuks BB Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789 [TBL] [Abstract][Full Text] [Related]
18. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells. La Motte RN; Sharpe AH; Bluestone JA; Mokyr MB J Immunol; 1998 Dec; 161(12):6552-8. PubMed ID: 9862681 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059 [TBL] [Abstract][Full Text] [Related]
20. Effects of L-histidinol on the susceptibility of P815 mastocytoma cells to selected anticancer drugs in vitro and in DBA/2J mice. Warrington RC; Cheng I; Fang WD J Natl Cancer Inst; 1987 Jun; 78(6):1177-83. PubMed ID: 3108563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]